Yemaachi Biotech

Yemaachi Biotech is a precision oncology company based in Accra, Ghana, founded in 2020. The company focuses on developing next-generation cancer diagnostics and therapeutics by utilizing sequencing data from genetically diverse African populations. Yemaachi aims to address the under-representation of these populations in genetic studies, creating the world's most diverse cancer bio-database to enhance drug effectiveness and advance inclusive precision oncology.

The company employs advanced techniques in immunogenomics, bioinformatics, and artificial intelligence to discover new products and optimize existing ones. Yemaachi offers a robust cancer bio-database for research and drug discovery, alongside affordable next-generation sequencing-based clinical testing services. The team, co-founded by immunology expert Yaw Bediako, includes specialists in various fields, all dedicated to building a sustainable research ecosystem in sub-Saharan Africa. Yemaachi collaborates with clinical, pharmaceutical, and biotech partners to leverage its data for impactful cancer research and treatment.